GATA2 deficiency resembles other inherited bone marrow failure syndromes in terms of high rates of transplant-related toxicity/mortality (TRT/TRM) after myeloablative regimens, due to cellular defects. The gene discussed is GATA2; the disease is bone marrow failure syndrome.